GENB
Generate Biomedicines, Inc.
GENB
Generate Biomedicines, Inc.
Shares of Generate Biomedicines Inc (NASDAQ:GENB) jumped more than 20% on Tuesday as investors positioned ahead of the expiration of the company's post-IPO lock-up period. The lock-up, which ends Wedn
Nvidia (NASDAQ: NVDA) has updated its stock portfolio, revealing a public equity portfolio worth approximately $63.4 billion as of June 30, 2026, according to a Form 13F filing.